genapsys case study solution

Harvard Business School →
Faculty & Research →
January 2014 (Revised December 2014)
HBS Case Collection

GenapSys: Business Models for the Genome

Format: Print
| Language: English
| Pages: 28

As GenapSys came closer to releasing its product, Esfandyarpour and his Senior Director of Operations and Strategy, Leila Rastegar (HBS '11), sat down to decide which of three business models they would choose to bring this device to market. In the first model, the company would sell sequencers at a higher price to those entities which already purchased sequencers, primarily major research labs and pharmaceutical firms, but position its machine as a faster alternative to existing technologies. In the second model, GenapSys would sell its sequencer at a lower price but charge more for the cartridges necessary to run a sample, and earn its primary revenue from these cartridges. The third model would see GenapSys sell its device at or around cost, but use the data customers generated to create a proprietary database of genetic information. Customers could pay to access the database for research, to create genetic tests, or for many other purposes. GenapSys would also build an online store with the genetic tests customers created.

Esfandyarpour's and Rastegar's decision would determine GenapSys' customer base and financial position for the coming years, and also impact development and capital needs of the firm. Which was the right model to bring the device to market and have a meaningful impact?

About The Authors

Richard G. Hamermesh

Joseph B. Fuller

Related work.

Faculty Research
November 2015

GenapSys Exercise - Introduction to Free Cash Flow Curves

GenapSys: Business Models for the Genome By: Richard G. Hamermesh, Joseph B. Fuller and Matthew Preble
GenapSys Exercise - Introduction to Free Cash Flow Curves By: Shikhar Ghosh, Joseph B. Fuller and Christopher Payton
GenapSys: Business Models for the Genome By: Joseph B. Fuller and Matthew G. Preble

ASeq Newsletter

GenapSys: Business Models for the Genome

I came across a case study on GenapSys on the Harvard Business Review website. I thought it would be fun to review it. Particularly given that liquidation of the company seems to be going ahead .

So I went ahead and paid the $9. The case study starts by discussing the sequencing market as of 2011, and why they think semiconductor sequencers will be disruptive:

Esfandyarpour noted that most sequencers used optical systems: DNA segments were labeled with dyes, and cameras visually examined it…. The complex nature of optical systems made such devices expensive, as well as labor- and time-intensive to operate.

For some reason it’s become received wisdom that optical = complicated. This isn’t really the case. Complex systems are complex. Simple ones simple.

To take one example. Both the iSeq and Ion Torrent platforms are disposable chip based systems. Both use sequencing-by-synthesis sequencing approaches. The iSeq however uses an optical readout.

The iSeq is a lower cost platform than any of Ion Torrents offerings, and I would say is a significantly less complicated approach… the MiSeq also uses consumer grade CMOS sensors , likely making both the platform and the consumables cheaper than Ion Torrent. Optics is only one factor that contributes to the overall complexity and cost of a platform.

Again in the preamble, the case study notes how different sequences are suited to different applications:

A machine’s efficacy for a given application was influenced by how DNA was prepared for and read by a sequencer. For example, one group of researchers found that the Ion Torrent platform was less adept at sequencing genomes made up of adenine and thymine (AT) base pairs, which could be an important factor for those working in specific fields, such as the study of malaria, as the researchers noted that over 80% of the malaria parasite’s genome was composed of AT base pairs. After testing a number of NGS platforms, the researchers concluded that, “The decision on whether to purchase one or the other [sequencer] will hinge on available resources, existing infrastructure and personal experience, available finances, and the type of applications being considered.”

This kind of hand waving is pretty common. It’s easy to hedge your bets and say “it depends”. The reality is that since 2011, it’s been hard to justify the use of Ion Torrent systems for technical or cost reasons (business and other factors may come into play).

The case study then goes on to discuss 3 possible models for GenapSys:

Traditional Sales Strategy - $40000 instrument, $500 to $1000 cartridges. $10000 servicing fee. Sell to research institutions.

Razor-and-Razor-Blade - $5000 to $7000 instrument, $200 cartridges at 50% margin.

Data Analytics - $3000 instrument or $2000/y lease. $50 to $100 cartridges. Customers give GenapSys copy of all data generated. “We could become the Google of genomics.” Easfandyarpour said. GenapSys would primarily derive its revenues from test royalties and from licensing or charging a subscription fee for access to its database.

Here’s what Esfandyarpour had to say:

Esfadyapour explained his views on each model: “The traditional model is a financially safe route. It’s a proven strategy and there’s a good chance we’ll be acquired, but I don’t see this as the way to change the future of medicine. With the razor-and-razor blade model, GenapSys can bring an affordable sequencing technology to new markets. However, it will ultimately be the company that controls the information that will succeed and change how healthcare is delivered.”

Ultimately GenapSys launched a $10000 instrument with $300 cartridges . I didn’t hear anything about a “data analytics” strategy. But then again, I’ve not really heard anything from any GenapSys customers… so they ended up somewhere between “traditional sales” and “Razor-and-Razor-Blade”.

While Esfandyarpour felt the “traditional sales strategy” would have been a safe route. I’m not so sure, at the price point suggested there would have been no strong advantage to the platform over an Ion Torrent instrument (or really, a MiSeq). And the fact that the company didn’t even end in acquisition suggests that no other players were particularly interested in the technology.

The “Razor-and-Razor-Blade” model clearly didn’t work out. It doesn’t even seem to work that well for a $1000 MinION with $100 to $900 runs (which doesn’t seem to generate significant revenue for ONT). I suspect to make this work you need to get run costs much lower than this and expend significant effort developing new applications around the sequencing platform to drive sales.

The “Data Analytics” model hasn’t really been tried. I suspect it’s very hard to find a sufficiently large market to engage with this model, both on the user side and in terms of users willing to pay for access to your database.

If you can push below a $100 COGS (closer to $10) and sell runs for $20, you might be at a price point where you can start to compete with qPCR and open up new applications . But this requires significant market development, and is far from an easy sell.

I do hope we see more cheap sequencers in the future but at present few players seem very interested in even developing MiSeq class instruments… I explore this, and other issues around GenapSys after the paywall break below.

This post is for paid subscribers

Marketing Process Analysis

Segmentation, targeting, positioning, marketing strategic planning, marketing 5 concepts analysis, swot analysis & matrix, porter five forces analysis, pestel / pest / step analysis, cage distance analysis international marketing analysis leadership, organizational resilience analysis, bcg matrix / growth share matrix analysis, block chain supply chain management, paei management roles, leadership with empathy & compassion, triple bottom line analysis, mckinsey 7s analysis, smart analysis, vuca analysis ai ethics analysis analytics, genapsys: business models for the genome case study solution & analysis / mba resources.

GenapSys: Business Models for the Genome
Innovation & Entrepreneurship / MBA Resources

Introduction to case study solution

EMBA Pro case study solution for GenapSys: Business Models for the Genome case study

At EMBA PRO , we provide corporate level professional case study solution. GenapSys: Business Models for the Genome case study is a Harvard Business School (HBR) case study written by Richard G. Hamermesh, Joseph Fuller, Matthew Preble. The GenapSys: Business Models for the Genome (referred as “Genapsys Sequencers” from here on) case study provides evaluation & decision scenario in field of Innovation & Entrepreneurship. It also touches upon business topics such as - Value proposition, Entrepreneurship, Health, Technology. Our immersive learning methodology from – case study discussions to simulations tools help MBA and EMBA professionals to - gain new insight, deepen their knowledge of the Innovation & Entrepreneurship field, and broaden their skill set.

Urgent - 12Hr

100% Plagiarism Free
On Time Delivery | 27x7
PayPal Secure
300 Words / Page

Case Description of GenapSys: Business Models for the Genome Case Study

GenapSys, a California-based startup, was soon to release a new DNA sequencer that the company's founder, Hesaam Esfandyarpour, believed was truly revolutionary. The sequencer would be substantially less expensive-potentially costing just a few thousand dollars-and smaller than other sequencers, many of which were large devices costing tens of thousands or hundreds of thousands of dollars. GenapSys' device, named GENIUS, could also quickly generate large amounts of data, as it was capable of sequencing an entire human genome in less than eight hours. At this price, GenapSys' device would be attractive to customers that had been unable to afford sequencers, such as smaller laboratories or hospitals, and even expand the market to include industries such as agriculture and biofuels. As GenapSys came closer to releasing its product, Esfandyarpour and his Senior Director of Operations and Strategy, Leila Rastegar (HBS '11), sat down to decide which of three business models they would choose to bring this device to market. In the first model, the company would sell sequencers at a higher price to those entities which already purchased sequencers, primarily major research labs and pharmaceutical firms, but position its machine as a faster alternative to existing technologies. In the second model, GenapSys would sell its sequencer at a lower price but charge more for the cartridges necessary to run a sample, and earn its primary revenue from these cartridges. The third model would see GenapSys sell its device at or around cost, but use the data customers generated to create a proprietary database of genetic information. Customers could pay to access the database for research, to create genetic tests, or for many other purposes. GenapSys would also build an online store with the genetic tests customers created. Esfandyarpour's and Rastegar's decision would determine GenapSys' customer base and financial position for the coming years, and also impact develop Esfandyarpour's and Rastegar's decision would determine GenapSys' customer base and financial position for the coming years, and also impact development and capital needs of the firm. Which was the right model to bring the device to market and have a meaningful impact?

Case Authors : Richard G. Hamermesh, Joseph Fuller, Matthew Preble

Topic : innovation & entrepreneurship, related areas : entrepreneurship, health, technology, what is the case study method how can you use it to write case solution for genapsys: business models for the genome case study.

Almost all of the case studies contain well defined situations. MBA and EMBA professional can take advantage of these situations to - apply theoretical framework, recommend new processes, and use quantitative methods to suggest course of action. Awareness of the common situations can help MBA & EMBA professionals read the case study more efficiently, discuss it more effectively among the team members, narrow down the options, and write cogently.

Case Study Solution Approaches

Three Step Approach to GenapSys: Business Models for the Genome Case Study Solution

The three step case study solution approach comprises – Conclusions – MBA & EMBA professionals should state their conclusions at the very start. It helps in communicating the points directly and the direction one took. Reasons – At the second stage provide the reasons for the conclusions. Why you choose one course of action over the other. For example why the change effort failed in the case and what can be done to rectify it. Or how the marketing budget can be better spent using social media rather than traditional media. Evidences – Finally you should provide evidences to support your reasons. It has to come from the data provided within the case study rather than data from outside world. Evidences should be both compelling and consistent. In case study method there is ‘no right’ answer, just how effectively you analyzed the situation based on incomplete information and multiple scenarios.

Case Study Solution of GenapSys: Business Models for the Genome

We write GenapSys: Business Models for the Genome case study solution using Harvard Business Review case writing framework & HBR Innovation & Entrepreneurship learning notes. We try to cover all the bases in the field of Innovation & Entrepreneurship, Entrepreneurship, Health, Technology and other related areas.

Objectives of using various frameworks in GenapSys: Business Models for the Genome case study solution

By using the above frameworks for GenapSys: Business Models for the Genome case study solutions, you can clearly draw conclusions on the following areas – What are the strength and weaknesses of Genapsys Sequencers (SWOT Analysis) What are external factors that are impacting the business environment (PESTEL Analysis) Should Genapsys Sequencers enter new market or launch new product (Opportunities & Threats from SWOT Analysis) What will be the expected profitability of the new products or services (Porter Five Forces Analysis) How it can improve the profitability in a given industry (Porter Value Chain Analysis) What are the resources needed to increase profitability (VRIO Analysis) Finally which business to continue, where to invest further and from which to get out (BCG Growth Share Analysis)

SWOT Analysis of GenapSys: Business Models for the Genome

SWOT analysis stands for – Strengths, Weaknesses, Opportunities and Threats. Strengths and Weaknesses are result of Genapsys Sequencers internal factors, while opportunities and threats arise from developments in external environment in which Genapsys Sequencers operates. SWOT analysis will help us in not only getting a better insight into Genapsys Sequencers present competitive advantage but also help us in how things have to evolve to maintain and consolidate the competitive advantage.

- Experienced and successful leadership team – Genapsys Sequencers management team has been a success over last decade by successfully predicting trends in the industry.

- Streamlined processes and efficient operation management – Genapsys Sequencers is one of the most efficient firms in its segment. The credit for the performance goes to successful execution and efficient operations management.

- Genapsys Sequencers business model can be easily replicated by competitors – According to Richard G. Hamermesh, Joseph Fuller, Matthew Preble , the business model of Genapsys Sequencers can be easily replicated by players in the industry.

- Little experience of international market – Even though it is a major player in local market, Genapsys Sequencers has little experience in international market. According to Richard G. Hamermesh, Joseph Fuller, Matthew Preble , Genapsys Sequencers needs international talent to penetrate into developing markets.

Opportunities

- Lucrative Opportunities in International Markets – Globalization has led to opportunities in the international market. Genapsys Sequencers is in prime position to tap on those opportunities and grow the market share.

- Developments in Artificial Intelligence – Genapsys Sequencers can use developments in artificial intelligence to better predict consumer demand, cater to niche segments, and make better recommendation engines.

- Age and life-cycle segmentation of Genapsys Sequencers shows that the company still hasn’t able to penetrate the millennial market.

- Home market marketing technique won’t work in new markets such as India and China where scale is prized over profitability.

Once all the factors mentioned in the GenapSys: Business Models for the Genome case study are organized based on SWOT analysis, just remove the non essential factors. This will help you in building a weighted SWOT analysis which reflects the real importance of factors rather than just tabulation of all the factors mentioned in the case.

What is PESTEL Analysis

PESTEL /PEST / STEP Analysis of GenapSys: Business Models for the Genome Case Study

PESTEL stands for – Political, Economic, Social, Technological, Environmental, and Legal factors that impact the macro environment in which Genapsys Sequencers operates in. Richard G. Hamermesh, Joseph Fuller, Matthew Preble provides extensive information about PESTEL factors in GenapSys: Business Models for the Genome case study.

Political Factors

- Little dangers of armed conflict – Based on the research done by international foreign policy institutions, it is safe to conclude that there is very little probability of country entering into an armed conflict with another state.

- Political consensus among various parties regarding taxation rate and investment policies. Over the years the country has progressively worked to lower the entry of barrier and streamline the tax structure.

Economic Factors

- According to Richard G. Hamermesh, Joseph Fuller, Matthew Preble . Genapsys Sequencers should closely monitor consumer disposable income level, household debt level, and level of efficiency of local financial markets.

- Foreign Exchange movement is also an indicator of economic stability. Genapsys Sequencers should closely consider the forex inflow and outflow. A number of Genapsys Sequencers competitors have lost money in countries such as Brazil, Argentina, and Venezuela due to volatile forex market.

Social Factors

- Leisure activities, social attitudes & power structures in society - are needed to be analyzed by Genapsys Sequencers before launching any new products as they will impact the demand of the products.

- Consumer buying behavior and consumer buying process – Genapsys Sequencers should closely follow the dynamics of why and how the consumers are buying the products both in existing categories and in segments that Genapsys Sequencers wants to enter.

Technological Factors

- 5G has potential to transform the business environment especially in terms of marketing and promotion for Genapsys Sequencers.

- Artificial intelligence and machine learning will give rise to importance of speed over planning. Genapsys Sequencers needs to build strategies to operate in such an environment.

Environmental Factors

- Consumer activism is significantly impacting Genapsys Sequencers branding, marketing and corporate social responsibility (CSR) initiatives.

- Environmental regulations can impact the cost structure of Genapsys Sequencers. It can further impact the cost of doing business in certain markets.

Legal Factors

- Intellectual property rights are one area where Genapsys Sequencers can face legal threats in some of the markets it is operating in.

- Property rights are also an area of concern for Genapsys Sequencers as it needs to make significant Entrepreneurship, Health, Technology infrastructure investment just to enter new market.

What are Porter Five Forces

Porter Five Forces Analysis of GenapSys: Business Models for the Genome

Competition among existing players, bargaining power of suppliers, bargaining power of buyers, threat of new entrants, and threat of substitutes.

What is VRIO Analysis

VRIO Analysis of GenapSys: Business Models for the Genome

VRIO stands for – Value of the resource that Genapsys Sequencers possess, Rareness of those resource, Imitation Risk that competitors pose, and Organizational Competence of Genapsys Sequencers. VRIO and VRIN analysis can help the firm.

What is Porter Value Chain

Porter Value Chain Analysis of GenapSys: Business Models for the Genome

As the name suggests Value Chain framework is developed by Michael Porter in 1980’s and it is primarily used for analyzing Genapsys Sequencers relative cost and value structure. Managers can use Porter Value Chain framework to disaggregate various processes and their relative costs in the Genapsys Sequencers. This will help in answering – the related costs and various sources of competitive advantages of Genapsys Sequencers in the markets it operates in. The process can also be done to competitors to understand their competitive advantages and competitive strategies. According to Michael Porter – Competitive Advantage is a relative term and has to be understood in the context of rivalry within an industry. So Value Chain competitive benchmarking should be done based on industry structure and bottlenecks.

What is BCG Growth Share Matrix

BCG Growth Share Matrix of GenapSys: Business Models for the Genome

BCG Growth Share Matrix is very valuable tool to analyze Genapsys Sequencers strategic positioning in various sectors that it operates in and strategic options that are available to it. Product Market segmentation in BCG Growth Share matrix should be done with great care as there can be a scenario where Genapsys Sequencers can be market leader in the industry without being a dominant player or segment leader in any of the segment. BCG analysis should comprise not only growth share of industry & Genapsys Sequencers business unit but also Genapsys Sequencers - overall profitability, level of debt, debt paying capacity, growth potential, expansion expertise, dividend requirements from shareholders, and overall competitive strength. Two key considerations while using BCG Growth Share Matrix for GenapSys: Business Models for the Genome case study solution - How to calculate Weighted Average Market Share using BCG Growth Share Matrix Relative Weighted Average Market Share Vs Largest Competitor

5C Marketing Analysis of GenapSys: Business Models for the Genome

4p marketing analysis of genapsys: business models for the genome, porter five forces analysis and solution of genapsys: business models for the genome, porter value chain analysis and solution of genapsys: business models for the genome, case memo & recommendation memo of genapsys: business models for the genome, blue ocean analysis and solution of genapsys: business models for the genome, marketing strategy and analysis genapsys: business models for the genome, vrio /vrin analysis & solution of genapsys: business models for the genome, pestel / step / pest analysis of genapsys: business models for the genome, swot analysis and solution of genapsys: business models for the genome, references & further readings.

Richard G. Hamermesh, Joseph Fuller, Matthew Preble (2018) , "GenapSys: Business Models for the Genome Harvard Business Review Case Study. Published by HBR Publications.

Case Study Solution & Analysis

Building an Integrated Biopharma Company: Crucell (B) Case Study Solution & Analysis
Inverness Medical Innovations--Born Global (A) Case Study Solution & Analysis
Ottawa Devices, Inc. (A) Case Study Solution & Analysis
Ottawa Devices, Inc. (B) Case Study Solution & Analysis
Developing Effective Middle Management in an Entrepreneurial Firm in China Case Study Solution & Analysis
"Make Mine a Russian Short-Hair, and Hold The Allergies, Please." Case Study Solution & Analysis
Can PACIV (Puerto Rico) Serve European Customers? (Video Supplement) Case Study Solution & Analysis
OncoMed Pharmaceuticals: Novel Anti-Cancer Stem Cell Therapeutics Case Study Solution & Analysis
LAE Enterprises Corp. Case Study Solution & Analysis
Fred Khosravi and AccessClosure Case Study Solution & Analysis

Explore More

Feel free to connect with us if you need business research.

You can download Excel Template of Case Study Solution & Analysis of GenapSys: Business Models for the Genome

Order Status
Testimonials
What Makes Us Different

Genapsys business models for genome Harvard Case Solution & Analysis

Home >> Harvard Case Study Analysis Solutions >> Genapsys business models for genome

Introduction:

This case study is dealing with the products of GENIUS DNA which is famous as the sequencer. The company which has been selected is a well-known company for Genome with the brand name as GenapSys that deals with high-tech instruments, which has the high value for money for its clients. This company is charging price which is very high for few services which shows that the company is trying to get maximum benefit within a short period of time. Price Skimming is the price charged for cartridges and service fees.

Company is operating at a low cost leadership strategy which is their competitive advantage over the other competitors such as Roche, Illumina and Life technologies. However, there is intense competitive rivalry among these companies and each of them try to take over the market share of the other company . Market leader position is maintained and retained by the competitor Illuminia which has the market share of around 66%.

Description of the Models:

Company has developed three models which needs in depth analysis of the situation, its target market, positioning strategy, segments and profitability as well as for pricing strategy to be followed. These three models consist of selling the sequencers and cartridges by using market penetration strategy with a unique feature in the product by creating product differentiation in the minds of the customers so as to attract more customers with some change in packaging and display of the product. They need to design the positioning strategy by showing the customer the additional benefits of products such as convenience and time saving with this innovative product model.

Second model was to choose a pricing strategy named as market penetration strategy. In this pricing strategy , company will be charging in the start lower prices for its product to increase its market share which will eventually attract more customers so their customer base will also in this way and they will be able to sell more of their products and make this model successful by targeting those customers who were unable to get their services due to high pricing. This will give them benefit in the long run and they will be able to get economies of scale by increasing the demand and they would be able to earn more profits by selling more quantity rather than charging high prices with low quantity.

Third model consists of a strategy which is unique in its nature and it seems to be a more aggressive approach to gauge the market shares of its competitors by charging the prices even lower than its costs so as to attract the customers of their competitors. However, they will generate profits by charging the fees from Genomics users, who will be paying them the access fees charged for using their services. Potential customers would be Pharmaceutical companies as well as the researches who use company’s platform for getting the required information.....................................

This is just a sample partial work. Please place the order on the website to get your own originally done case solution.

Hire us for Originally Written Case Solution/ Analysis

Like us and get updates:.

Harvard Case Solutions

Search Case Solutions

Accounting Case Solutions
Auditing Case Studies
Business Case Studies
Economics Case Solutions
Finance Case Studies Analysis
Harvard Case Study Analysis Solutions
Human Resource Cases
Ivey Case Solutions
Management Case Studies
Marketing HBS Case Solutions
Operations Management Case Studies
Supply Chain Management Cases
Taxation Case Studies

Contact us:

Check Order Status

How Does it Work?

Why TheCaseSolutions.com?

Alternate solution to the GenapSys Business Models for the Genome HBR case study

It is important to have more than one solution to the case study. This is the alternate solution that would be implemented if the original proposed solution is found infeasible or impossible due to a change in circumstances. The alternate solution for GenapSys Business Models for the Genome is presented in the same way as the original solution, where it consists of a corporate level strategy, business level strategy and other recommendations.

Implementation of GenapSys Business Models for the Genome Case Solution

The case study does not end at just providing recommendations to the issues at hand. One is also required to provide how these recommendations would be implemented. This is shown through a proper implementation framework. A detailed implementation framework helps in distinguishing between an average and an above average case study answer. A good implementation framework shows the proposed plan and how the organisations' resources would be used to achieve the objectives. It also lays down the changes needed to be made as well as the assumptions in the process.

A proper implementation framework shows that one has clearly understood the case study and the main issue within it.
It shows that one has been clarified with the HBR fundamentals on the topic.
It shows that the details provided in the case have been properly analysed.
It shows that one has developed an ability to prioritise recommendations and how these could be successfully implemented.
The implementation framework also helps by removing out any recommendations that are not practical or actionable as these could not be implemented. Therefore, the implementation framework ensures that the solution to the GenapSys Business Models for the Genome Harvard case is complete and properly answered.

Recommendations and Action Plan for GenapSys Business Models for the Genome case analysis

For GenapSys Business Models for the Genome, based on the SWOT Analysis, Porter Five Forces Analysis, PESTEL Analysis, VRIO analysis, Value Chain Analysis, BCG Matrix analysis, Ansoff Matrix analysis, and the Marketing Mix analysis, the recommendations and action plan are as follows:

GenapSys Business Models for the Genome should focus on making use of its strengths identified from the VRIO analysis to make the most of the opportunities identified from the PESTEL.
GenapSys Business Models for the Genome should enhance the value creating activities within its value chain.
GenapSys Business Models for the Genome should invest in its stars and cash cows, while getting rid of the dogs identified from the BCG Matrix analysis.
To achieve its overall corporate and business level objectives, it should make use of the marketing mix tools to obtain desired results from its target market.

Baron, E. (2015). How They Teach the Case Method At Harvard Business School. Retrieved from https://poetsandquants.com/2015/09/29/how-they-teach-the-case-method-at-harvard-business-school/

Bartol. K, & Martin, D. (1998). Management, 3rd edition. Boston: Irwin McGrawHill.

Free Management E-Books. (2013a). PESTLE Analysis. Retrieved from http://www.free-management-ebooks.com/dldebk-pdf/fme-pestle-analysis.pdf

Gupta, A. (2013). Environment & PEST analysis: an approach to the external business environment. International Journal of Modern Social Sciences, 2(1), 34-43.

Hambrick, D. C., MacMillan, I. C., & Day, D. L. (1982). Strategic attributes and performance in the BCG matrix—A PIMS-based analysis of industrial product businesses. Academy of Management Journal, 25(3), 510-531.

Hill, C., & Jones, G. (2010). Strategic Management Theory: An Integrated Approach, Ninth Ed. Mason, OH: South-Western, Cengage Learning.

Hussain, S., Khattak, J., Rizwan, A., & Latif, M. A. (2013). ANSOFF matrix, environment, and growth-an interactive triangle. Management and Administrative Sciences Review, 2(2), 196-206.

IIBMS. (2015). 7 Effective Steps to Solve Case Study. Retrieved from http://www.iibms.org/c-7-effective-steps-to-solve-case-study/

Kim, W. C., & Mauborgne, R. (2004). Blue ocean strategy. If you read nothing else on strategy, read thesebest-selling articles., 71.

Kotler, P., & Armstrong, G. (2010). Principles of marketing. Pearson education.

Kulkarni, N. (2018). 8 Tips to Help You Prepare for the Case Method. Retrieved from https://www.hbs.edu/mba/blog/post/8-tips-to-help-you-prepare-for-the-case-method

Lin, C., Tsai, H. L., Wu, Y. J., & Kiang, M. (2012). A fuzzy quantitative VRIO-based framework for evaluating organizational activities. Management Decision, 50(8), 1396-1411.

Nixon, J., & Helms, M. M. (2010). Exploring SWOT analysis – where are we now?: A review of academic research from the last decade. Journal of Strategy and Management, 3(3), 215-251.

Panagiotou, G. (2003). Bringing SWOT into Focus. Business Strategy Review, 14(2), 8-10.

Pickton, D. W., & Wright, S. (1998). What's swot in strategic analysis? Strategic Change, 7(2), 101-109.

Porter, M. E. (2001). The value chain and competitive advantage. Understanding Business Processes, 50-66.

Porter, M. E. (1985). Competitive advantage: creating and sustaining superior performance (Vol. 2). New York: Free Press.

Porter, M.E. (1979, March). Harvard Business Review: Strategic Planning, How Competitive Forces Shape Strategy. Retrieved July 7, 2016, from https://hbr.org/1979/03/how-competitive-forces-shape-strategy

Rastogi, N., & Trivedi, M. K. (2016). PESTLE Technique–a Tool to Identify External Risks in Construction Projects. International Research Journal of Engineering and Technology (IRJET), 3(1), 384-388.

Rauch, P. (2007). SWOT analyses and SWOT strategy formulation for forest owner cooperations in Austria. European Journal of Forest Research, 126(3), 413-420.

Warning! This article is only an example and cannot be used for research or reference purposes. If you need help with something similar, please submit your details here .

9413 Students can’t be wrong

PhD Experts

Rubyne Jexon

I got a top-notch paper at reasonable prices. I'm grateful for you guys' consideration and the most important step of discounts.

Ryder David

The support team really cares about customers and guides me in each step. Thanks for the proofread paper!

Absolutely worth the cost and my experience was really excellent with them.

Please keep up this good work! It was awesome and quite well written. I appreciate it!

Calculate the Price

(approx ~ 0.0 page), total price $0, next articles.

Building An Integrated Biopharma Company: Crucell (B) Case Analysis
Inverness Medical Innovations Born Global (A) Case Analysis
Ottawa Devices, Inc. (A) Case Analysis
Ottawa Devices, Inc. (B) Case Analysis
Developing Effective Middle Management In An Entrepreneurial Firm In China Case Analysis
Organizing For Innovation At Glenmark (A) Case Analysis
GSK's Acquisition Of Sirtris: Independence Or Integration? (Abridged) Case Analysis
Viscotech, Inc. Case Analysis
Birzeit Pharmaceutical Company: Marketing From Palestine Case Analysis
Organizing For Innovation At Glenmark (B) Case Analysis

"Make Mine A Russian Short Hair, And Hold The Allergies, Please." Case Analysis
Can PACIV (Puerto Rico) Serve European Customers? (Video Supplement) Case Analysis
OncoMed Pharmaceuticals: Novel Anti Cancer Stem Cell Therapeutics Case Analysis
LAE Enterprises Corp. Case Analysis
Fred Khosravi And AccessClosure Case Analysis
GSK's Acquisition Of Sirtris: Independence Or Integration? Case Analysis
Joint Juice, Spanish Version Case Analysis
Building An Integrated Biopharma Company: Crucell (A) Case Analysis
Conor Medsystems Case Analysis
Guidant: Radiation Therapy Case Analysis

Be a great writer or hire a greater one!

Academic writing has no room for errors and mistakes. If you have BIG dreams to score BIG, think out of the box and hire Case48 with BIG enough reputation.

Our Guarantees

Zero plagiarism, best quality, qualified writers, absolute privacy, timely delivery.

Interesting Fact

Most recent surveys suggest that around 76 % students try professional academic writing services at least once in their lifetime!

Allow Our Skilled Essay Writers to Proficiently Finish Your Paper.

We are here to help. Chat with us on WhatsApp for any queries.

Customer Representative

Business Case Studies
Global Research Group

Innovation & Entrepreneurship

GenapSys: Business Models for the Genome

GenapSys: Business Models for the Genome ^ 814050

Want to buy more than 1 copy? Contact: [email protected]

Product Description

Publication Date: January 05, 2014

Industry: Pharmaceutical industry

Source: Harvard Business School

This Product Also Appears In

Buy together, related products.

The Collective Intelligence Genome

Controversies of Progress: The Human Genome

The Circular Business Model

If you'd like to share this PDF, you can purchase copyright permissions by increasing the quantity.

Order for your team and save!

GenapSys Business Models For The Genome Case Study Solution Analysis

by HBR Twenty Two

GenapSys Business Models For The Genome Case Study Solution & Analysis. Get GenapSys Business Models For The Genome Case Study Analysis & Solution. Contact us directly at buycasesolutions(at)gmail(dot)com if you want to order for GenapSys Business Models For The Genome Case Solution, Case Analysis, Case Study Solution. Richard G. Hamermesh, Joseph B. Fuller, Matthew Preble Less

Email us for Any Case Solution at: [email protected] GenapSys Business Models for the Genome Case Study Solution & Analysis GenapSys Business Models for the Genome Case Study Solution & Analysis. Our tutors are available 24/7 to assist in your academic stuff, Our Professional writers are ready to serve you in services you need. Every Case Study Solution & Analysis is prepared from scratch, top quality, plagiarism free. Authors: Richard G. Hamermesh, Joseph B. Fuller, Matthew Preble Get Case Study Solution and Analysis of GenapSys Business Models for the Genome in a FAIR PRICE!! Steps for Case Study Solution & Analysis: 1. Introduction of GenapSys Business Models for the Genome Case Solution The GenapSys Business Models for the Genome case study is a Harvard Business Review case study, which presents a simulated practical experience to the reader allowing them to learn about real life problems in the business world. The GenapSys Business Models for the Genome case consisted of a central issue to the organization, which had to be identified, analysed and creative solutions had to be drawn to tackle the issue. This paper presents the solved GenapSys Business Models for the Genome case analysis and case solution. The method through which the analysis is done is mentioned, followed by the relevant tools used in finding the solution. The case solution first identifies the central issue to the GenapSys Business Models for the Genome case study, and the relevant stakeholders affected by this issue. This is known as the problem identification stage. After this, the relevant tools and models are used, which help in the case study analysis and case study solution. The tools used in identifying the solution consist of the SWOT Analysis, Porter Five Forces Analysis, PESTEL Analysis, VRIO analysis, Value Chain Analysis, BCG Matrix analysis, Ansoff Matrix analysis, and the Marketing Mix analysis. The solution consists of recommended strategies to overcome this central issue. It is a good idea to also propose alternative case study solutions, because if the main solution is not found feasible, then the alternative solutions could be implemented. Lastly, a good case study solution also includes an implementation plan for the recommendation Email us for Any Case Solution at: [email protected] Note: This article is just a sample and not an actual case solution. If you want original case solution, please place your order on the Email.

Email us for Any Case Solution at: [email protected] strategies. This shows how through a step-by-step procedure as to how the central issue can be resolved. 2. Problem Identification of GenapSys Business Models for the Genome Case Solution Harvard Business Review cases involve a central problem that is being faced by the organization and these problems affect a number of stakeholders. In the problem identification stage, the problem faced by GenapSys Business Models for the Genome is identified through reading of the case. This could be mentioned at the start of the reading, the middle or the end. At times in a case analysis, the problem may be clearly evident in the reading of the HBR case. At other times, finding the issue is the job of the person analysing the case. It is also important to understand what stakeholders are affected by the problem and how. The goals of the stakeholders and are the organization are also identified to ensure that the case study analysis are consistent with these. 3. Analysis of the GenapSys Business Models for the Genome HBR Case Study The objective of the case should be focused on. This is doing the GenapSys Business Models for the Genome Case Solution. This analysis can be proceeded in a step-by- step procedure to ensure that effective solutions are found. In the first step, a growth path of the company can be formulated that lays down its vision, mission and strategic aims. These can usually be developed using the company history is provided in the case. Company history is helpful in a Business Case study as it helps one understand what the scope of the solutions will be for the case study. The next step is of understanding the company; its people, their priorities and the overall culture. This can be done by using company history. It can also be done by looking at anecdotal instances of managers or employees that are usually included in an HBR case study description to give the reader a real feel of the situation. Lastly, a timeline of the issues and events in the case needs to be made. Arranging events in a timeline allows one to predict the next few events that are likely to take place. It also helps one in developing the case study solutions. The timeline also helps in understanding the continuous challenges that are being faced by the organisation. 4. SWOT analysis of GenapSys Business Models for the Genome An important tool that helps in addressing the central issue of the case and coming up with GenapSys Business Models for the Genome HBR case solution is the SWOT Email us for Any Case Solution at: [email protected] Note: This article is just a sample and not an actual case solution. If you want original case solution, please place your order on the Email.

Email us for Any Case Solution at: [email protected] analysis. The SWOT analysis is a strategic management tool that lists down in the form of a matrix, an organisation's internal strengths and weaknesses, and external opportunities and threats. It helps in the strategic analysis of GenapSys Business Models for the Genome Once this listing has been done, a clearer picture can be developed in regards to how strategies will be formed to address the main problem. For example, strengths will be used as an advantage in solving the issue. Therefore, the SWOT analysis is a helpful tool in coming up with the GenapSys Business Models for the Genome Case Study answers. One does not need to remain restricted to using the traditional SWOT analysis, but the advanced TOWS matrix or weighted average SWOT analysis can also be used. 5. Porter Five Forces Analysis for GenapSys Business Models for the Genome Another helpful tool in finding the case solutions is of Porter's Five Forces analysis. This is also a strategic tool that is used to analyse the competitive environment of the industry in which GenapSys Business Models for the Genome operates in. Analysis of the industry is important as businesses do not work in isolation in real life, but are affected by the business environment of the industry that they operate in. Harvard Business case studies represent real-life situations, and therefore, an analysis of the industry's competitive environment needs to be carried out to come up with more holistic case study solutions. In Porter's Five Forces analysis, the industry is analysed along 5 dimensions. • These are the threats that the industry faces due to new entrants. • It includes the threat of substitute products. • It includes the bargaining power of buyers in the industry. • It includes the bargaining power of suppliers in an industry. • Lastly, the overall rivalry or competition within the industry is analysed This tool helps one understand the relative powers of the major players in the industry and its overall competitive dynamics. Actionable and practical solutions can then be developed by keeping these factors into perspective. 6. PESTEL Analysis of GenapSys Business Models for the Genome Another helpful tool that should be used in finding the case study solutions is the PESTEL analysis. This also looks at the external business environment of the organisation helps in finding case study Analysis to real-life business issues as in HBR cases. • The PESTEL analysis particularly looks at the macro environmental factors that affect the industry. These are the political, environmental, social, Email us for Any Case Solution at: [email protected] Note: This article is just a sample and not an actual case solution. If you want original case solution, please place your order on the Email.

Email us for Any Case Solution at: [email protected] technological, environmental and legal (regulatory) factors affecting the industry. • Factors within each of these 6 should be listed down, and analysis should be made as to how these affect the organisation under question. 7. VRIO Analysis of GenapSys Business Models for the Genome This is an analysis carried out to know about the internal strengths and capabilities of GenapSys Business Models for the Genome . Under the VRIO analysis, the following steps are carried out: • The internal resources of GenapSys Business Models for the Genome are listed down. • Each of these resources are assessed in terms of the value it brings to the organization. • Each resource is assessed in terms of how rare it is. A rare resource is one that is not commonly used by competitors. • Each resource is assessed whether it could be imitated by competition easily or not. • Lastly, each resource is assessed in terms of whether the organization can use it to an advantage or not. • The analysis done on the 4 dimensions; Value, Rareness, Imitability, and Organization. If a resource is high on all of these 4, then it brings long-term competitive advantage. If a resource is high on Value, Rareness, and Imitability, then it brings an unused competitive advantage. If a resource is high on Value and Rareness, then it only brings temporary competitive advantage. If a resource is only valuable, then it’s a competitive parity. If it’s none, then it can be regarded as a competitive disadvantage. 8. Value Chain Analysis of GenapSys Business Models for the Genome The Value chain analysis of GenapSys Business Models for the Genome helps in identifying the activities of an organization, and how these add value in terms of cost reduction and differentiation. This tool is used in the case study analysis as follows: • The firm’s primary and support activities are listed down. • Identifying the importance of these activities in the cost of the product and the differentiation they produce. • Lastly, differentiation or cost reduction strategies are to be used for each of these activities to increase the overall value provided by these activities. Recognizing value creating activities and enhancing the value that they create allow GenapSys Business Models for the Genome to increase its competitive advantage. Email us for Any Case Solution at: [email protected] Note: This article is just a sample and not an actual case solution. If you want original case solution, please place your order on the Email.

Email us for Any Case Solution at: [email protected] 9. BCG Matrix of GenapSys Business Models for the Genome The BCG Matrix is an important tool in deciding whether an organization should invest or divest in its strategic business units. The matrix involves placing the strategic business units of a business in one of four categories; question marks, stars, dogs and cash cows. The placement in these categories depends on the relative market share of the organization and the market growth of these strategic business units. The steps to be followed in this analysis is as follows: • Identify the relative market share of each strategic business unit. • Identify the market growth of each strategic business unit. • Place these strategic business units in one of four categories. Question Marks are those strategic business units with high market share and low market growth rate. Stars are those strategic business units with high market share and high market growth rate. Cash Cows are those strategic business units with high market share and low market growth rate. Dogs are those strategic business units with low market share and low growth rate. • Relevant strategies should be implemented for each strategic business unit depending on its position in the matrix. The strategies identified from the GenapSys Business Models for the Genome BCG matrix and included in the case pdf. These are either to further develop the product, penetrate the market, develop the market, diversification, investing or divesting. 10. Ansoff Matrix of GenapSys Business Models for the Genome Ansoff Matrix is an important strategic tool to come up with future strategies for GenapSys Business Models for the Genome in the case solution. It helps decide whether an organization should pursue future expansion in new markets and products or should it focus on existing markets and products. • The organization can penetrate into existing markets with its existing products. This is known as market penetration strategy. • The organization can develop new products for the existing market. This is known as product development strategy. • The organization can enter new markets with its existing products. This is known as market development strategy. • The organization can enter into new markets with new products. This is known as a diversification strategy. The choice of strategy depends on the analysis of the previous tools used and the level of risk the organization is willing to take. Email us for Any Case Solution at: [email protected] Note: This article is just a sample and not an actual case solution. If you want original case solution, please place your order on the Email.

Email us for Any Case Solution at: [email protected] 11. Marketing Mix of GenapSys Business Models for the Genome GenapSys Business Models for the Genome needs to bring out certain responses from the market that it targets. To do so, it will need to use the marketing mix, which serves as a tool in helping bring out responses from the market. The 4 elements of the marketing mix are Product, Price, Place and Promotions. The following steps are required to carry out a marketing mix analysis and include this in the case study analysis. • Analyse the company’s products and devise strategies to improve the product offering of the company. • Analyse the company’s price points and devise strategies that could be based on competition, value or cost. • Analyse the company’s promotion mix. This includes the advertisement, public relations, personal selling, sales promotion, and direct marketing. Strategies will be devised which makes use of a few or all of these elements. • Analyse the company’s distribution and reach. Strategies can be devised to improve the availability of the company’s products. 12. GenapSys Business Models for the Genome Strategy The strategies devised and included in the GenapSys Business Models for the Genome case memo should have a strategy. A strategy is a strategy that involves firms seeking uncontested market spaces, which makes the competition of the company irrelevant. It involves coming up with new and unique products or ideas through innovation. This gives the organization a competitive advantage over other firms, unlike a red ocean strategy. 13. Competitors analysis of GenapSys Business Models for the Genome The PESTEL analysis discussed previously looked at the macro environmental factors affecting business, but not the microenvironmental factors. One of the microenvironmental factors are competitors, which are addressed by a competitor analysis. The Competitors analysis of GenapSys Business Models for the Genome looks at the direct and indirect competitors within the industry that it operates in. • This involves a detailed analysis of their actions and how these would affect the future strategies of GenapSys Business Models for the Genome . • It involves looking at the current market share of the company and its competitors. • It should compare the marketing mix elements of competitors, their supply chain, human resources, financial strength etc. Email us for Any Case Solution at: [email protected] Note: This article is just a sample and not an actual case solution. If you want original case solution, please place your order on the Email.

Email us for Any Case Solution at: [email protected] • It also should look at the potential opportunities and threats that these competitors pose on the company. 14. Organisation of the Analysis into GenapSys Business Models for the Genome Case Study Solution Once various tools have been used to analyse the case, the findings of this analysis need to be incorporated into practical and actionable solutions. These solutions will also be the GenapSys Business Models for the Genome case answers. These are usually in the form of strategies that the organisation can adopt. The following step- by-step procedure can be used to organise the Harvard Business case solution and recommendations: • The first step of the solution is to come up with a corporate level strategy for the organisation. This part consists of solutions that address issues faced by the organisation on a strategic level. This could include suggestions, changes or recommendations to the company's vision, mission and its strategic objectives. It can include recommendations on how the organisation can work towards achieving these strategic objectives. Furthermore, it needs to be explained how the stated recommendations will help in solving the main issue mentioned in the case and where the company will stand in the future as a result of these. • The second step of the solution is to come up with a business level strategy. The HBR case studies may present issues faced by a part of the organisation. For example, the issues may be stated for marketing and the role of a marketing manager needs to be assumed. So, recommendations and suggestions need to address the strategy of the marketing department in this case. Therefore, the strategic objectives of this business unit (Marketing) will be laid down in the solutions and recommendations will be made as to how to achieve these objectives. Similar would be the case for any other business unit or department such as human resources, finance, IT etc. The important thing to note here is that the business level strategy needs to be aligned with the overall corporate strategy of the organisation. For example, if one suggests the organisation to focus on differentiation for competitive advantage as a corporate level strategy, then it can't be recommended for the GenapSys Business Models for the Genome Case Study Solution that the business unit should focus on costs. • The third step is not compulsory but depends from case to case. In some HBR case studies, one may be required to analyse an issue at a department. This issue may be analysed for a manager or employee as well. In these cases, recommendations need to be made for these people. The solution may state that objectives that these people need to achieve and how these objectives would be achieved. Email us for Any Case Solution at: [email protected] Note: This article is just a sample and not an actual case solution. If you want original case solution, please place your order on the Email.

Email us for Any Case Solution at: [email protected] The case study analysis and solution, and GenapSys Business Models for the Genome case answers should be written down in the GenapSys Business Models for the Genome case memo, clearly identifying which part shows what. The GenapSys Business Models for the Genome case should be in a professional format, presenting points clearly that are well understood by the reader. 15. Alternate solution to the GenapSys Business Models for the Genome HBR case study It is important to have more than one solution to the case study. This is the alternate solution that would be implemented if the original proposed solution is found infeasible or impossible due to a change in circumstances. The alternate solution for GenapSys Business Models for the Genome is presented in the same way as the original solution, where it consists of a corporate level strategy, business level strategy and other recommendations. 16. Implementation of GenapSys Business Models for the Genome Case Solution The case study does not end at just providing recommendations to the issues at hand. One is also required to provide how these recommendations would be implemented. This is shown through a proper implementation framework. A detailed implementation framework helps in distinguishing between an average and an above average case study answer. A good implementation framework shows the proposed plan and how the organisations' resources would be used to achieve the objectives. It also lays down the changes needed to be made as well as the assumptions in the process. • A proper implementation framework shows that one has clearly understood the case study and the main issue within it. • It shows that one has been clarified with the HBR fundamentals on the topic. • It shows that the details provided in the case have been properly analysed. • It shows that one has developed an ability to prioritise recommendations and how these could be successfully implemented. • The implementation framework also helps by removing out any recommendations that are not practical or actionable as these could not be implemented. Therefore, the implementation framework ensures that the solution to the GenapSys Business Models for the Genome Harvard case is complete and properly answered. 17. Recommendations and Action Plan for GenapSys Business Models for the Genome case analysis Email us for Any Case Solution at: [email protected] Note: This article is just a sample and not an actual case solution. If you want original case solution, please place your order on the Email.

Email us for Any Case Solution at: [email protected] For GenapSys Business Models for the Genome, based on the SWOT Analysis, Porter Five Forces Analysis, PESTEL Analysis, VRIO analysis, Value Chain Analysis, BCG Matrix analysis, Ansoff Matrix analysis, and the Marketing Mix analysis, the recommendations and action plan are as follows: • GenapSys Business Models for the Genome should focus on making use of its strengths identified from the VRIO analysis to make the most of the opportunities identified from the PESTEL. • GenapSys Business Models for the Genome should enhance the value creating activities within its value chain. • GenapSys Business Models for the Genome should invest in its stars and cash cows, while getting rid of the dogs identified from the BCG Matrix analysis. • To achieve its overall corporate and business level objectives, it should make use of the marketing mix tools to obtain desired results from its target market. Email us for Any Case Solution at: [email protected] Note: This article is just a sample and not an actual case solution. If you want original case solution, please place your order on the Email.

Related publications
Add to favorites

Predictive Analytics Workshops
Corporate Strategy Workshops
Advanced Excel for MBA
Powerpoint Workshops
Digital Transformation
Competing on Business Analytics
Aligning Analytics with Strategy
Building & Sustaining Competitive Advantages
Corporate Strategy
Aligning Strategy & Sales
Digital Marketing
Hypothesis Testing
Time Series Analysis
Regression Analysis
Machine Learning
Marketing Strategy
Branding & Advertising
Risk Management
Hedging Strategies
Network Plotting
Bar Charts & Time Series
Technical Analysis of Stocks MACD
NPV Worksheet
ABC Analysis Worksheet
WACC Worksheet
Porter 5 Forces
Porter Value Chain
Amazing Charts
Garnett Chart
HBR Case Solution
4P Analysis
5C Analysis
NPV Analysis
SWOT Analysis
PESTEL Analysis
Cost Optimization

GenapSys: Business Models for the Genome

Innovation & Entrepreneurship / MBA EMBA Resources

Next Case Study Solutions

Building an Integrated Biopharma Company: Crucell (B) Case Study Solution
Inverness Medical Innovations--Born Global (A) Case Study Solution
Ottawa Devices, Inc. (A) Case Study Solution
Ottawa Devices, Inc. (B) Case Study Solution
Developing Effective Middle Management in an Entrepreneurial Firm in China Case Study Solution

Previous Case Solutions

"Make Mine a Russian Short-Hair, and Hold The Allergies, Please." Case Study Solution
Can PACIV (Puerto Rico) Serve European Customers? (Video Supplement) Case Study Solution
OncoMed Pharmaceuticals: Novel Anti-Cancer Stem Cell Therapeutics Case Study Solution
LAE Enterprises Corp. Case Study Solution
Fred Khosravi and AccessClosure Case Study Solution

Predictive Analytics

April 4, 2024

Popular Tags

Case study solutions.

Case Study Solution | Assignment Help | Case Help

Genapsys: business models for the genome description.

Case Description GenapSys: Business Models for the Genome

Strategic managment tools used in case study analysis of genapsys: business models for the genome, step 1. problem identification in genapsys: business models for the genome case study, step 2. external environment analysis - pestel / pest / step analysis of genapsys: business models for the genome case study, step 3. industry specific / porter five forces analysis of genapsys: business models for the genome case study, step 4. evaluating alternatives / swot analysis of genapsys: business models for the genome case study, step 5. porter value chain analysis / vrio / vrin analysis genapsys: business models for the genome case study, step 6. recommendations genapsys: business models for the genome case study, step 7. basis of recommendations for genapsys: business models for the genome case study, quality & on time delivery.

100% money back guarantee if the quality doesn't match the promise

100% Plagiarism Free

If the work we produce contain plagiarism then we payback 1000 USD

Paypal Secure

All your payments are secure with Paypal security.

300 Words per Page

We provide 300 words per page unlike competitors' 250 or 275

Free Title Page, Citation Page, References, Exhibits, Revision, Charts

Case study solutions are career defining. Order your custom solution now.

Case Analysis of GenapSys: Business Models for the Genome

GenapSys: Business Models for the Genome is a Harvard Business (HBR) Case Study on Innovation & Entrepreneurship , Texas Business School provides HBR case study assignment help for just $9. Texas Business School(TBS) case study solution is based on HBR Case Study Method framework, TBS expertise & global insights. GenapSys: Business Models for the Genome is designed and drafted in a manner to allow the HBR case study reader to analyze a real-world problem by putting reader into the position of the decision maker. GenapSys: Business Models for the Genome case study will help professionals, MBA, EMBA, and leaders to develop a broad and clear understanding of casecategory challenges. GenapSys: Business Models for the Genome will also provide insight into areas such as – wordlist , strategy, leadership, sales and marketing, and negotiations.

Case Study Solutions Background Work

GenapSys: Business Models for the Genome case study solution is focused on solving the strategic and operational challenges the protagonist of the case is facing. The challenges involve – evaluation of strategic options, key role of Innovation & Entrepreneurship, leadership qualities of the protagonist, and dynamics of the external environment. The challenge in front of the protagonist, of GenapSys: Business Models for the Genome, is to not only build a competitive position of the organization but also to sustain it over a period of time.

Strategic Management Tools Used in Case Study Solution

The GenapSys: Business Models for the Genome case study solution requires the MBA, EMBA, executive, professional to have a deep understanding of various strategic management tools such as SWOT Analysis, PESTEL Analysis / PEST Analysis / STEP Analysis, Porter Five Forces Analysis, Go To Market Strategy, BCG Matrix Analysis, Porter Value Chain Analysis, Ansoff Matrix Analysis, VRIO / VRIN and Marketing Mix Analysis.

Texas Business School Approach to Innovation & Entrepreneurship Solutions

In the Texas Business School, GenapSys: Business Models for the Genome case study solution – following strategic tools are used - SWOT Analysis, PESTEL Analysis / PEST Analysis / STEP Analysis, Porter Five Forces Analysis, Go To Market Strategy, BCG Matrix Analysis, Porter Value Chain Analysis, Ansoff Matrix Analysis, VRIO / VRIN and Marketing Mix Analysis. We have additionally used the concept of supply chain management and leadership framework to build a comprehensive case study solution for the case – GenapSys: Business Models for the Genome

Step 1 – Problem Identification of GenapSys: Business Models for the Genome - Harvard Business School Case Study

The first step to solve HBR GenapSys: Business Models for the Genome case study solution is to identify the problem present in the case. The problem statement of the case is provided in the beginning of the case where the protagonist is contemplating various options in the face of numerous challenges that Genapsys Sequencers is facing right now. Even though the problem statement is essentially – “Innovation & Entrepreneurship” challenge but it has impacted by others factors such as communication in the organization, uncertainty in the external environment, leadership in Genapsys Sequencers, style of leadership and organization structure, marketing and sales, organizational behavior, strategy, internal politics, stakeholders priorities and more.

Step 2 – External Environment Analysis

Texas Business School approach of case study analysis – Conclusion, Reasons, Evidences - provides a framework to analyze every HBR case study. It requires conducting robust external environmental analysis to decipher evidences for the reasons presented in the GenapSys: Business Models for the Genome. The external environment analysis of GenapSys: Business Models for the Genome will ensure that we are keeping a tab on the macro-environment factors that are directly and indirectly impacting the business of the firm.

What is PESTEL Analysis? Briefly Explained

PESTEL stands for political, economic, social, technological, environmental and legal factors that impact the external environment of firm in GenapSys: Business Models for the Genome case study. PESTEL analysis of " GenapSys: Business Models for the Genome" can help us understand why the organization is performing badly, what are the factors in the external environment that are impacting the performance of the organization, and how the organization can either manage or mitigate the impact of these external factors.

How to do PESTEL / PEST / STEP Analysis? What are the components of PESTEL Analysis?

As mentioned above PESTEL Analysis has six elements – political, economic, social, technological, environmental, and legal. All the six elements are explained in context with GenapSys: Business Models for the Genome macro-environment and how it impacts the businesses of the firm.

How to do PESTEL Analysis for GenapSys: Business Models for the Genome

To do comprehensive PESTEL analysis of case study – GenapSys: Business Models for the Genome , we have researched numerous components under the six factors of PESTEL analysis.

Political Factors that Impact GenapSys: Business Models for the Genome

Political factors impact seven key decision making areas – economic environment, socio-cultural environment, rate of innovation & investment in research & development, environmental laws, legal requirements, and acceptance of new technologies.

Government policies have significant impact on the business environment of any country. The firm in “ GenapSys: Business Models for the Genome ” needs to navigate these policy decisions to create either an edge for itself or reduce the negative impact of the policy as far as possible.

Data safety laws – The countries in which Genapsys Sequencers is operating, firms are required to store customer data within the premises of the country. Genapsys Sequencers needs to restructure its IT policies to accommodate these changes. In the EU countries, firms are required to make special provision for privacy issues and other laws.

Competition Regulations – Numerous countries have strong competition laws both regarding the monopoly conditions and day to day fair business practices. GenapSys: Business Models for the Genome has numerous instances where the competition regulations aspects can be scrutinized.

Import restrictions on products – Before entering the new market, Genapsys Sequencers in case study GenapSys: Business Models for the Genome" should look into the import restrictions that may be present in the prospective market.

Export restrictions on products – Apart from direct product export restrictions in field of technology and agriculture, a number of countries also have capital controls. Genapsys Sequencers in case study “ GenapSys: Business Models for the Genome ” should look into these export restrictions policies.

Foreign Direct Investment Policies – Government policies favors local companies over international policies, Genapsys Sequencers in case study “ GenapSys: Business Models for the Genome ” should understand in minute details regarding the Foreign Direct Investment policies of the prospective market.

Corporate Taxes – The rate of taxes is often used by governments to lure foreign direct investments or increase domestic investment in a certain sector. Corporate taxation can be divided into two categories – taxes on profits and taxes on operations. Taxes on profits number is important for companies that already have a sustainable business model, while taxes on operations is far more significant for companies that are looking to set up new plants or operations.

Tariffs – Chekout how much tariffs the firm needs to pay in the “ GenapSys: Business Models for the Genome ” case study. The level of tariffs will determine the viability of the business model that the firm is contemplating. If the tariffs are high then it will be extremely difficult to compete with the local competitors. But if the tariffs are between 5-10% then Genapsys Sequencers can compete against other competitors.

Research and Development Subsidies and Policies – Governments often provide tax breaks and other incentives for companies to innovate in various sectors of priority. Managers at GenapSys: Business Models for the Genome case study have to assess whether their business can benefit from such government assistance and subsidies.

Consumer protection – Different countries have different consumer protection laws. Managers need to clarify not only the consumer protection laws in advance but also legal implications if the firm fails to meet any of them.

Political System and Its Implications – Different political systems have different approach to free market and entrepreneurship. Managers need to assess these factors even before entering the market.

Freedom of Press is critical for fair trade and transparency. Countries where freedom of press is not prevalent there are high chances of both political and commercial corruption.

Corruption level – Genapsys Sequencers needs to assess the level of corruptions both at the official level and at the market level, even before entering a new market. To tackle the menace of corruption – a firm should have a clear SOP that provides managers at each level what to do when they encounter instances of either systematic corruption or bureaucrats looking to take bribes from the firm.

Independence of judiciary – It is critical for fair business practices. If a country doesn’t have independent judiciary then there is no point entry into such a country for business.

Government attitude towards trade unions – Different political systems and government have different attitude towards trade unions and collective bargaining. The firm needs to assess – its comfort dealing with the unions and regulations regarding unions in a given market or industry. If both are on the same page then it makes sense to enter, otherwise it doesn’t.

Economic Factors that Impact GenapSys: Business Models for the Genome

Social factors that impact genapsys: business models for the genome, technological factors that impact genapsys: business models for the genome, environmental factors that impact genapsys: business models for the genome, legal factors that impact genapsys: business models for the genome, step 3 – industry specific analysis, what is porter five forces analysis, step 4 – swot analysis / internal environment analysis, step 5 – porter value chain / vrio / vrin analysis, step 6 – evaluating alternatives & recommendations, step 7 – basis for recommendations, references :: genapsys: business models for the genome case study solution.

sales & marketing ,
leadership ,
corporate governance ,
Advertising & Branding ,
Corporate Social Responsibility (CSR) ,
innovative list

Amanda Watson

Leave your thought here

USEFUL LINKS

Subscribe to our newsletter to receive news on update.

Dark Brown Leather Watch

$200.00 $180.00

Dining Chair

$300.00 $220.00

Creative Wooden Stand

$100.00 $80.00

2 x $180.00

2 x $220.00

Subtotal: $200.00

Free Shipping on All Orders Over $100!

Wooden round table

$360.00 $300.00

Hurley Dry-Fit Chino Short. Men's chino short. Outseam Length: 19 Dri-FIT Technology helps keep you dry and comfortable. Made with sweat-wicking fabric. Fitted waist with belt loops. Button waist with zip fly provides a classic look and feel .

Genapsys business models for genome Case Solution & Answer

Home » Case Study Analysis Solutions » Genapsys business models for genome

Target Market of Business models:

Target market of the 1 st model will be those who are existing customers of the company who will be getting more convenience and their time will be saved. Target market of 2 nd model would be the customers who were underserved unable to use the product due to high prices whereas the target market of 3 rd model would be the researchers and pharmaceutical companies who will pay them for using their information portal and under this model they will be charging even less than cost from its customers. This will lead to entering into the geographical expansion by targeting the customers of competitors.

If we charge high prices from our customers or cut down our prices vary rapidly we need to make our sales and marketing very strong so that our pricing and product should justify its position in the minds of customers so it does not lose its creditability by cutting down its prices and considered as low value proposition. Moreover, salesforce team should be provided training to gain confidence of their customers by marketing its products in major universities and hospitals.

Products need heavy investment and capital funding requirements as all these business models need to be developed after doing thorough research and developing the prototypes so that their investments does not become sunk cost rather they try to capitalize their investment to maximize their profits. They were meeting the additional capital requirements by funding from the banks and additional subscribed capital by the owners for all the available options.

In the option 2, customer base will increase which will eventually increase its revenue however, the operating costs and selling expense will also increase in this case as they would have to pay more to its sales team so they need to charge lower profits from its customers and gaining economies of scale and using low cost leadership strategy with product differentiation which will eventually result in the best cost leadership strategy.

Gene Sequencing

To make the human body function properly, it is necessary that gene needs to be available in the body consisting of the DNA molecules but it has adverse effect if it is not available in the body, it can create abnormalities as well as diseases can be generated and defective proteins can be produced from this abnormality.

Gene Sequencer is used for detecting and recording abnormalities. It is very expensive and time consuming task to operate sequencer and it is not everyoneâ€™s piece of cake to own the sequencers for day to day operations.

Market can be developed by doing market research on those universities and hospitals where sequencers are used, hospitals can be the potential market for this sequencer and they will able to afford it. This will lead to develop target market of the product and the company will be setting its budget according to the market structure and customer needs, soit does not cost the company a higher opportunity cost by raising capital and paying more financial cost for its sequencers. Uncertainties can be occurred due to the wrong detection by sequencer and mishandling of the machines while operating them by the relevant parties will lead to the loss for the company. However, it may provide bias results for the company. Now the sequencer is moving towards the next generation sequencing which provides higher processing results than the traditional one. Choosing the compatible sequencer was also a challenge which may produce the bias result which is full of errors so to rectify it next generation sequencer should be used………………..

This is just a sample partial work. Please place the order on the website to get your own originally done case solution.

LOOK FOR A FREE CASE STUDY SOLUTION

Please turn on JavaScript in your browser

It appears your web browser is not using JavaScript. Without it, some pages won't work properly. Please adjust the settings in your browser to make sure JavaScript is turned on.

Case Studies

Solo Stove fires up sales with Chase customers

Campaign results

$300K+ in incremental sales
$750K+ in total sales
94% new customer transactions
4.7MM impressions

Opening account

For an outdoor brand like Solo Stove, seasonality is top of mind. And fall is considered a prime time for fire pits — especially when it comes to the lightweight, portable, backyard-friendly designs Solo sells. The Solostove.com team knew there was untapped potential to entice more people to try their premium smokeless stoves. It was just a matter of figuring out how to spark interest with new audiences. And Chase Media Solutions’ transaction-based marketing platform was ideal for the task.

Branching out

Solo Stove’s primary goal was to kindle incremental sales online during Q4 of 2023. To determine the right audience for their campaign with Chase Media Solutions, the team took a cue from the brand itself. An elevated product pairs well with a sophisticated audience. With this in mind, the campaign was targeted exclusively to cardholders within one of the bank’s most premium portfolios: Chase Sapphire ® . Next, the team crafted a campaign offer construct with a minimum spending requirement to ensure customers would make higher-ticket purchases. In addition, Chase Media Solutions leveraged proprietary transaction data to implement tracking that would allow Solo Stove to measure performance between both new and existing customers. When all was in place, the campaign launched on Chase’s owned, brand-safe digital channels.

Total gains

Solo Stove’s transaction-based marketing campaign stoked an impressive $300K+ in incremental sales (46% incrementality for new customers) with purchases from 2,098 new customers (those who had not purchased from the brand in the last year). It garnered a total of 4.7MM impressions with a 3% activation rate .

Extra credit

“The incremental ROAS of our campaign with Chase Media Solutions shows there is real opportunity for growth with Chase’s large customer base. And the ability to target high-value consumers, like Sapphire cardholders, and segment based on spending patterns is incredibly valuable. It’s become an essential part of our marketing strategy.”

IMAGES

Calaméo
Case Solution GenapSys Business Models for the Genome
GenapSys: Business Models for the Genome Case Solution And Analysis
GenapSys Case Study
Genapsys Case Analysis
Genapsys sequencing prep system

VIDEO

Case Study Solution(Section-E) Science CBSE Class-X Board Exam
Genesys Experience Orchestration Demo
board copy maths
International Business
संबंध एवं फलन कक्षा-12 Exercise 1.1 Question-2,3,4,5,6 #maths#mathematics#students#youtube#viral
Invenergy uses GE's digital wind solutions to get an advantage in operations

COMMENTS

GenapSys: Business Models for the Genome
GenapSys would also build an online store with the genetic tests customers created. Esfandyarpour's and Rastegar's decision would determine GenapSys' customer base and financial position for the coming years, and also impact development and capital needs of the firm. ... Harvard Business School Case 814-050, January 2014. (Revised December 2014.)
GenapSys Business Models for the Genome Case Study Solution
To do an effective HBR case study analysis, you need to explore the following areas: 1. Company history: The GenapSys Business Models for the Genome case study consists of the history of the company given at the start. Reading it thoroughly will provide you with an understanding of the company's aims and objectives.
GenapSys Business Models for the Genome Case Solution
This case study presents a detailed strategic analysis of GenapSys Business Models for the Genome. The case analysis covers key managerial and strategic issues that GenapSys Business Models for the Genome is currently facing due to challenging internal and external environments. ... The case solution first conducts the strategic analysis by ...
GenapSys: Business Models for the Genome
The case study then goes on to discuss 3 possible models for GenapSys: Traditional Sales Strategy - $40000 instrument, $500 to $1000 cartridges. $10000 servicing fee. Sell to research institutions. Razor-and-Razor-Blade - $5000 to $7000 instrument, $200 cartridges at 50% margin.
GenapSys: Business Models for the Genome Case Solution And Analysis
GenapSys: Business Models for the Genome Case Solution,GenapSys: Business Models for the Genome Case Analysis, GenapSys: Business Models for the Genome Case Study Solution, A California-based startup, was soon to release a brand new DNA sequencer that the business founder, Hesaam Esfandyarpour, believed was really
GenapSys: Business Models for the Genome Case Study Analysis & Solution
Step 2 - Reading the GenapSys: Business Models for the Genome HBR Case Study. To write an emphatic case study analysis and provide pragmatic and actionable solutions, you must have a strong grasps of the facts and the central problem of the HBR case study. Begin slowly - underline the details and sketch out the business case study description ...
GenapSys Business Models for the Genome Case Study solution
The case solution focuses on understanding the central issue(s) in the case. The case study solution then uses strategic tools and models to solve the case and makes strategic recommendations for the GenapSys Business Models for the Genome (Abratt & Bendixen, 2018; Iacobucci, 2021).
GenapSys: Business Models for the Genome Case Study Solution for
Home » Case Study Analysis Solutions » GenapSys: Business Models for the Genome. This Case is aboutÂ ENTREPRENEURSHIP, HEALTH, TECHNOLOGY. PUBLICATION DATE: January 05, 2014 PRODUCT #: 814050-HCB-ENG. A California-based startup, was shortly to release a fresh DNA sequencer that Hesaam Esfandyarpour, the business's creator, considered as ...
GenapSys: Business Models for the Genome Case Study Solution & Analysis
Three Step Approach to GenapSys: Business Models for the Genome Case Study Solution. Conclusions - MBA & EMBA professionals should state their conclusions at the very start. It helps in communicating the points directly and the direction one took. Reasons - At the second stage provide the reasons for the conclusions.
GenapSys: Business Models for the Genome Change Management Analysis
Step 1 - Establish a sense of urgency. What are areas that require urgent change management efforts in the " GenapSys: Business Models for the Genome " case study. Some of the areas that require urgent changes are - organizing sales force to meet competitive realities, building new organizational structure to enter new markets or explore ...
Genapsys business models for genome Case Solution And Analysis, HBR
Genapsys business models for genome Case Solution,Genapsys business models for genome Case Analysis, Genapsys business models for genome Case Study Solution, Introduction: This case study is dealing with the products of GENIUS DNA which is famous as the sequencer. The company which has been selected is a
GenapSys Business Models for the Genome Case Analysis and Case Solution
The case solution first identifies the central issue to the GenapSys Business Models for the Genome case study, and the relevant stakeholders affected by this issue. This is known as the problem identification stage. After this, the relevant tools and models are used, which help in the case study analysis and case study solution.
GenapSys: Business Models for the Genome
Product Description. GenapSys, a California-based startup, was soon to release a new DNA sequencer that the company's founder, Hesaam Esfandyarpour, believed was truly revolutionary. The sequencer would be substantially less expensive-potentially costing just a few thousand dollars-and smaller than other sequencers, many of which were large ...
GENAPSYS: BUSINESS MODELS FOR THE GENOME Case Solution ...
https://www.thecasesolutions.comThis Case Is About GENAPSYS: BUSINESS MODELS FOR THE GENOMEGet Your GENAPSYS: BUSINESS MODELS FOR THE GENOME Case Solution a...
GenapSys Business Models For The Genome Case Study Solution ...
Every Case Study Solution & Analysis is prepared from scratch, top quality, plagiarism free. Authors: Richard G. Hamermesh, Joseph B. Fuller, Matthew Preble Get Case Study Solution and Analysis of GenapSys Business Models for the Genome in a FAIR PRICE!! Steps for Case Study Solution & Analysis: 1.
Case Study Solution of GenapSys: Business Models for the Genome
Case Study Analysis & Solution of GenapSys: Business Models for the Genome , written by Richard G. Hamermesh, Joseph Fuller, Matthew Preble, Case Analysis, Assignment Help, PESTEL, SWOT, Porter 5 Forces, Porter Value Chain
Genapsys business models for genome Case Study Solution for Harvard HBR
This is just a sample partial work. Please place the order on the website to get your own originally done case solution. Genapsys business models for genome Target Market of Business models: Target market of the 1st model will be those who are existing customers of the company who will be getting more.
Solved Case Study: GenapSys
Case Study: GenapSys - Business Models for the Genome. GenapSys, a California-based startup, was soon to release a new DNA sequencer that the company's founder, Hesaam Esfandyarpour, believed was truly revolutionary. The sequencer would be substantially less expensive-potentially costing just a few thousand dollars-and smaller than other ...
GenapSys Business Models for the Genome.docx
Solutions Available. Southern New Hampshire University. DAD 220. GenapSys Case Study Analysis. Solutions Available. Brigham Young University, Idaho. BUSINESS M B399. CLM 059 Exam.docx. Solutions Available. Defense Acquisition University. CLM 059. test prep. Lec26+2015-09-02+Genomics.
Genapsys Case Study Essay.docx
GenapSys Case Study Esfandyarpour and Rastegar are considering between different strategies, the three options that they have are: Traditional Sales Strategy: In this model, the company would sell sequencers at a higher price to those entities, which already purchased sequencers, primarily major research labs and pharmaceutical firms, but position its machine as a faster alternative to ...
How health care pioneer GenapSys unraveled
GenapSys and Love Health were unable to come to an agreement on that investment. The same GenapSys bankruptcy court response includes an exhibit of a July 8 proposed Love Health term sheet for a ...
Twist Bioscience
"Through this partnership, GenapSys enables researchers to have access to an efficient, end-to-end sequencing solution with almost limitless applications in life sciences." The collaboration with Twist Bioscience will take effect immediately, with GenapSys integrating the new library preparation and target enrichment products starting in Q2 ...
Air Canada case study
Branching out. Air Canada leveraged Chase Media Solutions' exclusive purchase data to create a campaign targeting new-to-the-airline customers within Chase's 80MM audience. The team identified a transaction-based segment composed primarily of customers with no purchase history with the brand in the last year. Then, working together, Chase ...
Solo Stove Fires Up Sales With Chase Customers
Total gains. Solo Stove's transaction-based marketing campaign stoked an impressive $300K+ in incremental sales (46% incrementality for new customers) with purchases from 2,098 new customers (those who had not purchased from the brand in the last year). It garnered a total of 4.7MM impressions with a 3% activation rate.

GenapSys: Business Models for the Genome

About The Authors

Richard G. Hamermesh

Joseph B. Fuller

GenapSys Exercise - Introduction to Free Cash Flow Curves

ASeq Newsletter

GenapSys: Business Models for the Genome

This post is for paid subscribers

Marketing Process Analysis

EMBA Pro case study solution for GenapSys: Business Models for the Genome case study

Urgent - 12Hr

Case Description of GenapSys: Business Models for the Genome Case Study

Case Authors : Richard G. Hamermesh, Joseph Fuller, Matthew Preble

Three Step Approach to GenapSys: Business Models for the Genome Case Study Solution

Case Study Solution of GenapSys: Business Models for the Genome

Objectives of using various frameworks in GenapSys: Business Models for the Genome case study solution

SWOT Analysis of GenapSys: Business Models for the Genome

Opportunities

PESTEL /PEST / STEP Analysis of GenapSys: Business Models for the Genome Case Study

Political Factors

Economic Factors

Social Factors

Technological Factors

Environmental Factors

Legal Factors

Porter Five Forces Analysis of GenapSys: Business Models for the Genome

VRIO Analysis of GenapSys: Business Models for the Genome

Porter Value Chain Analysis of GenapSys: Business Models for the Genome

BCG Growth Share Matrix of GenapSys: Business Models for the Genome

5C Marketing Analysis of GenapSys: Business Models for the Genome

Case Study Solution & Analysis

Explore More

Genapsys business models for genome Harvard Case Solution & Analysis

Introduction:

Description of the Models:

Related Case Solutions & Analyses:

Hire us for Originally Written Case Solution/ Analysis

Search Case Solutions

More From Harvard Case Study Analysis Solutions

Contact us:

Check Order Status

How Does it Work?

Why TheCaseSolutions.com?

Alternate solution to the GenapSys Business Models for the Genome HBR case study

Implementation of GenapSys Business Models for the Genome Case Solution

Recommendations and Action Plan for GenapSys Business Models for the Genome case analysis

9413 Students can’t be wrong

Calculate the Price

Previous Articles

Be a great writer or hire a greater one!

Our Guarantees

Interesting Fact

Allow Our Skilled Essay Writers to Proficiently Finish Your Paper.

Customer Representative

Innovation & Entrepreneurship

GenapSys: Business Models for the Genome

GenapSys: Business Models for the Genome ^ 814050

Product Description

This Product Also Appears In

The Collective Intelligence Genome

Controversies of Progress: The Human Genome

The Circular Business Model

Order for your team and save!

GenapSys Business Models For The Genome Case Study Solution Analysis

GenapSys: Business Models for the Genome

Next Case Study Solutions

Previous Case Solutions

Predictive Analytics

Popular Tags

Case Study Solution | Assignment Help | Case Help

Case Description GenapSys: Business Models for the Genome

100% Plagiarism Free

Paypal Secure

300 Words per Page

Case Analysis of GenapSys: Business Models for the Genome

Case Study Solutions Background Work

Strategic Management Tools Used in Case Study Solution

Texas Business School Approach to Innovation & Entrepreneurship Solutions

Step 1 – Problem Identification of GenapSys: Business Models for the Genome - Harvard Business School Case Study

Step 2 – External Environment Analysis